Source: centralcharts

Press Release: Nanomix : Nanomix Initiates New Clinical Study for the eLab S1 Panel

SAN LEANDRO, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) ("Nanomix" or the "Company") , a leader in the development of

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Thomas Schlumpberger's photo - CEO of Nanomix

CEO

Thomas Schlumpberger

CEO Approval Rating

82/100

Read more